Drug Rediscovery for Rare Immune Mediated Inflammatory Diseases

Clinical trial NCT06285539 · RECRUITING

Trial details

NCT number: NCT06285539
Sponsor: UMC Utrecht
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Behcet's Disease Idiopathic Inflammatory Myopathies IgG4-related Disease

Start date: 2024-03-12
Primary completion: 2026-12-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.